United Therapeutics Corp. has requested federal approval to start selling an inhaled version of its pulmonary arterial hypertension drug on the market. (UTHR)
Covidien announced Monday the appointment of a new research and development leadership team for its Pharmaceutical Products and Imaging Solutions businesses, based in St. Louis. (COV) (TYC)